ICM
CTSH icon

Invenomic Capital Management’s Cognizant CTSH Stock Holding History

Invenomic Capital Management’s Portfolio CTSH Stock Details CTSH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-317,554
Closed -$20.7M – 153
2023
Q2 		$20.7M Sell
317,554
-20,314
-6% -$1.26M 1.05% 36
2023
Q1 		$20.6M Buy
337,868
+9,237
+3% +$578K 1.16% 31
2022
Q4 		$18.8M Buy
328,631
+228,451
+228% +$13.4M 1.28% 22
2022
Q3 		$5.75M Buy
+100,180
New +$6.56M 0.49% 68

Other funds holding CTSH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Invenomic Capital Management's CTSH Position: Q3 2023 in Review

Invenomic Capital Management sold out of Cognizant (CTSH) in Q3 2023, closing a stake of 317,554 shares — an estimated $20.7M sold.

Invenomic Capital Management first reported a position in CTSH in Q3 2022 and held it in 4 quarters. The position peaked at $20.7M in Q2 2023. 851 funds tracked by Wall St. Rank hold CTSH as of Q3 2023.

  • Invenomic Capital Management reported no remaining Cognizant position as of Q3 2023 after selling out during the quarter.
  • Invenomic Capital Management sold 317,554 Cognizant shares in Q3 2023, an estimated $20.7M.
  • Invenomic Capital Management first reported a position in Cognizant in Q3 2022 and held it in 4 quarters.
  • Invenomic Capital Management's Cognizant position peaked at $20.7M in Q2 2023.
  • 851 funds tracked by Wall St. Rank held Cognizant as of Q3 2023.

Based on Invenomic Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.